Year: 2025
Type: article
Abstract: This cross-sectional study assesses how the European Medicines Agency incorporated routinely collected clinical data into its approval processes from 2020 to 2023.
Source: JAMA Network Open
Authors: Magdalena Bachinger, Maciej A. Jankowski, Aaron S. Kesselheim, Nils Krüger
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,000
Funders: Arnold Ventures, Deutsche Herzstiftung
OpenAlex ID: W4415966131
